Home-Based Long-Acting Antiretroviral Treatment Offers Safe and Effective HIV Management
Recent research has demonstrated that long-acting injectable antiretroviral therapy (ART) can be administered safely and effectively in a home setting for individuals living with HIV. A study conducted by MUSC Health Infectious Diseases expert Dr. Eric Meissner, published in Clinical Infectious Diseases, found that patients receiving ART injections at home reported high satisfaction levels, comparable to those receiving treatment in clinical settings. The study involved 33 participants choosing between clinic and home administration, with most maintaining their original choice over 12 months. All participants achieved viral suppression, and no serious safety concerns arose in either group.
Typically, long-acting injectable ART given at intervals of two months has been administered exclusively in clinics. However, the study explored the feasibility of at-home treatment, which could significantly improve adherence for patients facing challenges with daily pills or transportation logistics. Dr. Meissner, an associate professor at the Medical University of South Carolina, highlighted that convenience was the primary factor influencing patients’ treatment location choices.
In the study, medications were mailed to patients’ homes, stored in refrigerators, and administered by licensed practical nurses (LPNs). Participants appreciated the consistency of care and the ease of receiving treatment at home. Despite logistical hurdles—such as insurance reimbursement for at-home treatment—the findings suggest that expanding access to home-based injections could enhance adherence and overall health outcomes for many individuals living with HIV.
While current regulations and reimbursement policies pose challenges, the encouraging results support continued efforts to integrate home-based injectable HIV treatment into routine care, offering a safe, feasible, and satisfying option for patients. The study underscores the importance of providing more flexible treatment choices to improve adherence, health outcomes, and quality of life for those managing HIV.
Source: https://medicalxpress.com/news/2025-04-persons-hiv-safely-effectively-antiretroviral.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Vitamin D Supplements May Help Slow Aging by Preserving Telomere Length
Emerging research indicates that vitamin D supplements may help slow biological aging by preserving telomere length, potentially reducing age-related disease risks. Learn more about this promising discovery in our latest article.
Persistent Pain After Heart Attack Linked to Increased Mortality Risk, Comparable to Smoking
New research reveals that ongoing pain a year after a heart attack can significantly increase the risk of premature death, on par with smoking and high blood pressure. The study highlights the importance of recognizing chronic pain as an independent health risk in cardiovascular care.
Impact of Immigration Policies and Medicaid Cuts on Healthcare Employment Growth in 2025
Healthcare employment in 2025 remains strong but faces challenges from immigration restrictions and Medicaid cuts, threatening future growth and access.
Understanding the Difference Between Palliative Care and Hospice
Discover the key differences between palliative care and hospice, and learn how early palliative intervention can improve quality of life for patients with serious illnesses.